The FY2022-1 Small Business Innovation Research Contract (SBIR) Program solicitation has been posted!
“The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) invite small business concerns (SBCs) to submit research proposals under this Small Business Innovation Research (SBIR) Contract Solicitation. Firms with the capability to conduct research and development (R&D) in any of the health-related topic areas described in Section 12.0, and to commercialize the results of that R&D, are encouraged to participate.”
Please see link above for specific solicitations.
Contract funding is very different from grant funding, and a project needs to be a very (very) good fit to pursue this mechanism. NIAID offers a useful resource to compare differences between grants and contracts – although written specifically for NIAID, these guidelines generally apply across NIH contracts.
Wondering if your company could win non-dilutive funding through an SBIR contract? Have questions about understanding the solicitation details? Reach out today and we will connect you with one of our experts!
- The following research topics are anticipated to be included in SBIR Contract Solicitation PHS-2023-1:
NATIONAL INSTITUTES OF HEALTH (NIH)
NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES (NCATS):
Topic 024 – Small Manufacturing Systems to Produce Research Grade Pharmaceutical Intermediates
NATIONAL CANCER INSTITUTE (NCI):
Topic 455 – Point-of-Care Detection of Prostate Specific Antigen
Topic 456 – Rapid and Affordable Point-of-Care HPV Diagnostics for Cervical Cancer Control
Topic 457 – Technologies for Detecting Tumor-Derived Cell Clusters
Topic 458 – Microbiome-Based Tests for Cancer Research, Diagnosis, Prognosis and/or Patient Management
Topic 459 – Automated Software for Point-of-Care Testing to Identify Cancer-Associated Malnutrition
Topic 460 – Evaluation Datasets as Medical Device Development Tools for Testing Cancer Technologies
Topic 461 – Ultra-Fast Dose Rate (FLASH) Radiation Detectors and Safety Systems for Cancer Treatment
Topic 462 – Organ-on-Chip for Preclinical and Translational Radiobiological Studies
Topic 463 – Translation of Novel Cancer-specific Imaging Agents and Techniques to Mediate Successful Image-guided Cancer Interventions
Topic 464 – Cloud-Based Multimodal Data Analysis Software for the Cancer Research Data Commons
Topic 465 – Cancer Prevention and Treatment Clinical Trials Tools for Recruitment and Retention of Diverse Populations
NATIONAL INSTITUTE ON AGING (NIA):
Topic 010 – Technology to facilitate characterization of the exosome in under –resourced populations for AD/ADRD Studies
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID):
Topic 124 – Development of Next-Generation Devices and Materials-Based Platforms for the Administration of HIV-1 Broadly Neutralizing Antibodies
Topic 125 – Development of Long-Acting Treatments for HCV Cure
Topic 126 – Rapid Diagnostic Assays for Self-Monitoring of Acute or Rebound HIV-1 Infection
Topic 127 – Multiplexed Patient Administered Diagnostics for Hepatitis B, Hepatitis C, and HIV
Topic 128 – Adjuvant Development for Vaccines for Infectious and Immune-Mediated Diseases
Topic 129 – Reagents for Immunologic Analysis of Non-mammalian and Underrepresented Mammalian Models
Topic 130 – Adjuvant Discovery and Down-Selection for Vaccines against Infectious and Immune-Mediated Diseases
Topic 131 – Development of Bacteriophage for Treatment of Mycobacterial Infections
Topic 132 – Novel Diagnostic Biomarker Discovery and Validation for Malaria and Select Neglected Tropical Diseases (NTDs)
Topic 133 – Development of a Serological Test for Herpes Simplex Types 1 and 2 Infections
Topic 134 – Alternatives to Benzathine Penicillin for Treatment of Syphilis
Topic 135 – Software or Web Services to Automate Metadata Enrichment and Standardization for Data on Infectious and Immune – Mediated Diseases
Topic 136 – Software or Web Services to Re-Represent Existing Scientific Data and Knowledge into a Knowledge Graph Format
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (NHLBI):
Topic 115 – Clinical Instrument for Para-Hydrogen (pH2) Based Signal Amplification by Reversible Exchange (SABRE) for Hyperpolarizing 13C-Pyruvate and Other Probes for MRI Imaging
NATIONAL INSTITUTE OF MENTAL HEALTH (NIMH):
Topic 001 – Point-of-Care HIV Viral Load and Drug Adherence Assays
Topic 002 – Development of novel In-vitro and In-vivo Models to support NeuroHIV Research
CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC)
NATIONAL CENTER FOR EMERGING ZOONOTIC AND INFECTIOUS DISEASE (NCEZID):
Topic 03 – Development of SHERLOCK Assay for Detection of High Threat Orthopoxviruses
NATIONAL CENTER FOR HIV/AIDS, VIRAL HEPATITIS, STD, AND TB PREVENTION (NCHHSTP):
Topic 055 – Software Solutions: Bridging the Gap between Public Health and Pharmacies
Topic 056 – EHR Algorithm to Identify Persons with HIV Not in Care
Topic 057 – Device for point-of-care nucleic acid purification and detection of HCV
NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES (NCIRD):
Topic 036 – Improved Diagnostic Assays for Measles, Mumps, Rubella, and Varicella
Topic 037 – Rapid Diagnostic Tests for Measles, Mumps, Rubella, and Varicella
Webinar resources are now available:
Are you ready to get started on winning the non-dilutive funding your company needs?
Recent Comments